lifestyle.sourcefed.com

Author: ImageneBio, Inc.

ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update

May 7, 2026
ImageneBio Announces $30 Million Private Placement

April 13, 2026
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 17, 2026
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

March 10, 2026
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer

February 12, 2026